Evidence map›Paper›PMID 41908382›Full record

ArticleACS omega2026

Improving hERG Cardiotoxicity Prediction via SMILES Transformer, Molecular Fingerprints, and Layer-Wise Self-Adaptive Graph Attention Network.

Cheikh Beidja, Abdelmajid Bousselham, Zakariae En-Naimani, Mohammed Mestari

Abstract read
In one paragraph

Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Cheikh Beidja2IACS Laboratory, ENSET Mohammedia, Hassan II University of Casablanca, BP 159, Bd Hassan II, Mohammedia 28810, Morocco.ORCID https://orcid.org/0009-0009-6931-3180
Abdelmajid Bousselham2IACS Laboratory, ENSET Mohammedia, Hassan II University of Casablanca, BP 159, Bd Hassan II, Mohammedia 28810, Morocco.ORCID https://orcid.org/0000-0001-5458-2294
Zakariae En-Naimani2IACS Laboratory, ENSET Mohammedia, Hassan II University of Casablanca, BP 159, Bd Hassan II, Mohammedia 28810, Morocco.
Mohammed Mestari2IACS Laboratory, ENSET Mohammedia, Hassan II University of Casablanca, BP 159, Bd Hassan II, Mohammedia 28810, Morocco.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Blocking of hERG (human ether-à-go-go-related gene) potassium channels by certain drug-like molecules remains a major obstacle in pharmaceutical development, as it can induce QT interval prolongation and serious cardiotoxic effects. Experimental assessment of hERG liability is accurate but costly and time-consuming, which motivates the development of reliable computational screening tools. In this work, we propose TDMFLSGAT (transformer-enhanced deep learning model with molecular fingerprints and layer-wise self-adaptive graph attention network), a multimodal architecture that integrates three complementary molecular representations. Sequential information from SMILES strings is encoded with a Transformer, graph-based structural features are extracted using an adaptive graph attention mechanism, and physicochemical patterns are captured through a diverse set of molecular fingerprints. These modalities are fused into a unified representation for robust classification. To enhance model transparency, we further incorporate a multimodal interpretability framework that combines attention-based analyses and fingerprint-level explanations to highlight structural motifs associated with hERG blockade. Under 5-fold cross-validation, TDMFLSGAT achieves strong and well-balanced predictive performance, with an accuracy of 0.823, an AUC of 0.901, an average precision (AP) of 0.915, a sensitivity of 0.850, a specificity of 0.792, an NPV of 0.810, a PPV of 0.834, and an MCC of 0.641. The inclusion of AP confirms that these performance gains remain robust under class imbalance, providing a more realistic assessment of model reliability. Overall, these results indicate that TDMFLSGAT offers both accurate predictions and meaningful mechanistic insights, making it a promising tool for early stage cardiotoxicity screening in drug discovery.

Identifiers

PMID41908382
PMCPMC13019261

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.